Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
3 min read
AcuraStem confirms licensing contract with Takeda to progress PIKFYVE treatment methods
3 October 2023
AcuraStem proclaimed it has signed a licensing deal with Takeda.
Drug Insights
4 min read
An In-depth Analysis of Calcifediol's R&D Progress and Mechanism of Action on Drug Target
3 October 2023
This article summarized the latest R&D progress of Calcifediol, the Mechanism of Action for Calcifediol, and the drug target R&D trends for Calcifediol.
Valuable Targets
6 min read
New drugs in the field of diabetes - SGLT1 Inhibitors
3 October 2023
SGLT1, or sodium-glucose co-transporter 1, plays a crucial role in the human body by facilitating the absorption of glucose and galactose in the small intestine.
Drug Insights
4 min read
Folinic acid: Detailed Review of its Transformative R&D Success, Mechanism of Action, and Drug Target
3 October 2023
This article summarized the latest R&D progress of Folinic acid, the Mechanism of Action for Folinic acid, and the drug target R&D trends for Folinic acid.
Latest Hotspot
3 min read
Alvotech reveals Japan’s authorization of AVT04 (ustekinumab), a biosimilar counterpart to Stelara®
3 October 2023
Alvotech revealed that its distribution associate in Japan, Fuji Pharma Co., Ltd., has obtained commercialisation authorization for AVT04 (ustekinumab).
Drug Insights
4 min read
Pharmaceutical Insights: Ephedrine Sulfate's R&D Progress and its Mechanism of Action on Drug Target
3 October 2023
This article summarized the latest R&D progress of Ephedrine Sulfate, the Mechanism of Action for Ephedrine Sulfate, and the drug target R&D trends for Ephedrine Sulfate.
Valuable Targets
6 min read
RAS Inhibitors: A New Weapon Targeting a Deadly Factor in Cancer
3 October 2023
RAS is a small G protein composed of 188 amino acids, primarily distributed on the inner membrane of the cytoplasm in cells, its activity undergoes dynamic changes.
Drug Insights
4 min read
Exploring Fluphenazine Decanoate's Revolutionary R&D Successes and its Mechanism of Action on Drug Target
3 October 2023
This article summarized the latest R&D progress of Fluphenazine Decanoate, the Mechanism of Action for Fluphenazine Decanoate, and the drug target R&D trends for Fluphenazine Decanoate.
Latest Hotspot
3 min read
TransCode Therapeutics reports encouraging results in preclinical glioblastoma trials with its main treatment, TTX-MC138
3 October 2023
TransCode Therapeutics has reported positive findings with its primary treatment candidate, TTX-MC138, in mouse models with human glioblastoma multiforme tumors.
Drug Insights
4 min read
Decoding Hydrochlorothiazide/Lisinopril: A Comprehensive Study of its R&D Trends and Mechanism on Drug Target
1 October 2023
This article summarized the latest R&D progress of Hydrochlorothiazide/Lisinopril, the Mechanism of Action for Hydrochlorothiazide/Lisinopril, and the drug target R&D trends for Hydrochlorothiazide/Lisinopril.
Valuable Targets
6 min read
Potential Therapeutic Drug for Autoimmune and Neurodegenerative Diseases - RIPK1 Inhibitors
1 October 2023
RIPK1, also known as Receptor-interacting serine/threonine-protein kinase 1, is a multi-domain protein that includes an N-terminal kinase domain, intermediate domain, and a C-terminal death domain.
Drug Insights
4 min read
Deep Scientific Insights on Isophane Insulin's R&D Progress, Mechanism of Action, and Drug Target
1 October 2023
This article summarized the latest R&D progress of Isophane Insulin, the Mechanism of Action for Isophane Insulin, and the drug target R&D trends for Isophane Insulin.